0
0.5
1
1.5
2+
Mortality
-56%
Improvement
Relative Risk
Ventilation
90%
Adjusted discharge ratio
49%
Favipiravir Alamer et al. LATE TREATMENT
Is late treatment with favipiravir beneficial for COVID-19?
Retrospective 456 patients in Saudi Arabia
Lower ventilation (p<0.0001) and higher discharge (p<0.0001)
c19early.org
Alamer et al., Current Medical Researc.., May 2021
Favors favipiravir
Favors control